334 related articles for article (PubMed ID: 24672017)
1. Mechanisms of dopamine D1 receptor-mediated ERK1/2 activation in the parkinsonian striatum and their modulation by metabotropic glutamate receptor type 5.
Fieblinger T; Sebastianutto I; Alcacer C; Bimpisidis Z; Maslava N; Sandberg S; Engblom D; Cenci MA
J Neurosci; 2014 Mar; 34(13):4728-40. PubMed ID: 24672017
[TBL] [Abstract][Full Text] [Related]
2. Blockade of metabotropic glutamate receptor 5 attenuates axonal degeneration in 6-hydroxydopamine-induced model of Parkinson's disease.
Zhang JN; Huang YL; Yang HM; Wang Y; Gu L; Zhang H
Mol Cell Neurosci; 2021 Jan; 110():103572. PubMed ID: 33248235
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D1 receptor modulation of glutamate receptor messenger RNA levels in the neocortex and neostriatum of unilaterally 6-hydroxydopamine-lesioned rats.
Rodríguez-Puertas R; Herrera-Marschitz M; Koistinaho J; Hökfelt T
Neuroscience; 1999 Mar; 89(3):781-97. PubMed ID: 10199613
[TBL] [Abstract][Full Text] [Related]
4. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
Pollack AE; Yates TM
Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
[TBL] [Abstract][Full Text] [Related]
5. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
St-Hilaire M; Landry E; Lévesque D; Rouillard C
Neurobiol Dis; 2005 Nov; 20(2):450-60. PubMed ID: 15896973
[TBL] [Abstract][Full Text] [Related]
6. Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat.
Dupre KB; Eskow KL; Barnum CJ; Bishop C
Neuropharmacology; 2008 Dec; 55(8):1321-8. PubMed ID: 18824001
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat.
Lanza K; Chemakin K; Lefkowitz S; Saito C; Chambers N; Bishop C
Psychopharmacology (Berl); 2020 Jan; 237(1):155-165. PubMed ID: 31435690
[TBL] [Abstract][Full Text] [Related]
8. Persistent activation of the D1R/Shp-2/Erk1/2 pathway in l-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease.
Fiorentini C; Savoia P; Savoldi D; Barbon A; Missale C
Neurobiol Dis; 2013 Jun; 54():339-48. PubMed ID: 23328768
[TBL] [Abstract][Full Text] [Related]
9. Metabotropic glutamate mGluR5 receptor blockade opposes abnormal involuntary movements and the increases in glutamic acid decarboxylase mRNA levels induced by l-DOPA in striatal neurons of 6-hydroxydopamine-lesioned rats.
Yamamoto N; Soghomonian JJ
Neuroscience; 2009 Nov; 163(4):1171-80. PubMed ID: 19660528
[TBL] [Abstract][Full Text] [Related]
10. Genetic Knockdown of mGluR5 in Striatal D1R-Containing Neurons Attenuates L-DOPA-Induced Dyskinesia in Aphakia Mice.
García-Montes JR; Solís O; Enríquez-Traba J; Ruiz-DeDiego I; Drucker-Colín R; Moratalla R
Mol Neurobiol; 2019 Jun; 56(6):4037-4050. PubMed ID: 30259400
[TBL] [Abstract][Full Text] [Related]
11. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
Doucet JP; Nakabeppu Y; Bedard PJ; Hope BT; Nestler EJ; Jasmin BJ; Chen JS; Iadarola MJ; St-Jean M; Wigle N; Blanchet P; Grondin R; Robertson GS
Eur J Neurosci; 1996 Feb; 8(2):365-81. PubMed ID: 8714707
[TBL] [Abstract][Full Text] [Related]
12. Differential enhancement of ERK, PKA and Ca
Mariani LL; Longueville S; Girault JA; Hervé D; Gervasi N
Neurobiol Dis; 2019 Oct; 130():104506. PubMed ID: 31220556
[TBL] [Abstract][Full Text] [Related]
13. D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson's disease.
Sebastianutto I; Goyet E; Andreoli L; Font-Ingles J; Moreno-Delgado D; Bouquier N; Jahannault-Talignani C; Moutin E; Di Menna L; Maslava N; Pin JP; Fagni L; Nicoletti F; Ango F; Cenci MA; Perroy J
J Clin Invest; 2020 Mar; 130(3):1168-1184. PubMed ID: 32039920
[TBL] [Abstract][Full Text] [Related]
14. L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice.
Suárez LM; Solís O; Caramés JM; Taravini IR; Solís JM; Murer MG; Moratalla R
Biol Psychiatry; 2014 May; 75(9):711-22. PubMed ID: 23769604
[TBL] [Abstract][Full Text] [Related]
15. Synergistic interaction between an adenosine antagonist and a D1 dopamine agonist on rotational behavior and striatal c-Fos induction in 6-hydroxydopamine-lesioned rats.
Pollack AE; Fink JS
Brain Res; 1996 Dec; 743(1-2):124-30. PubMed ID: 9017239
[TBL] [Abstract][Full Text] [Related]
16. Dopamine receptor cooperativity synergistically drives dyskinesia, motor behavior, and striatal GABA neurotransmission in hemiparkinsonian rats.
Kiessling CY; Lanza K; Feinberg E; Bishop C
Neuropharmacology; 2020 Sep; 174():108138. PubMed ID: 32492451
[TBL] [Abstract][Full Text] [Related]
17. Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons.
Frau L; Morelli M; Simola N
Exp Neurol; 2013 Sep; 247():663-72. PubMed ID: 23499830
[TBL] [Abstract][Full Text] [Related]
18. Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: effects of combined treatment and possible mechanisms of action.
Iderberg H; Rylander D; Bimpisidis Z; Cenci MA
Exp Neurol; 2013 Dec; 250():116-24. PubMed ID: 24029003
[TBL] [Abstract][Full Text] [Related]
19. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
[TBL] [Abstract][Full Text] [Related]
20. BDNF Overexpression Increases Striatal D3 Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia.
Scheggi S; Rossi F; Corsi S; Fanni S; Tronci E; Ludovica C; Vargiu R; Gambarana C; Muñoz A; Stancampiano R; Björklund A; Carta M
J Parkinsons Dis; 2020; 10(4):1503-1514. PubMed ID: 32651332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]